A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).

Status:
Recruiting

Trial end date:
2024-03-31

Target enrollment:

Participant gender:

Phase I, open-label, multi-center study

Phase 1

Chugai Pharmaceutical